Anti-Infective Agents - Global Market Outlook (2017-2023)

Anti-Infective Agents - Global Market Outlook (2017-2023)

  • Published: December 2017
  • ID: SMRC16868

According to Stratistics MRC,the Global Anti-Infective Agents Market is accounted for $86.7 billion in 2016 and expected to grow at a CAGR of 3.8% to reach $113.16 billion by 2023. Rising incidences of infectious diseases such as HIV, H1N1, and Ebola virus, awareness amongst the patients, commercialization of pipeline products, Govt collaborating with pharmaceutical companies for the development of new agents, development of new multi-drug resistance against micro-organisms are boosting the market growth. Treatment rates for communicable diseases in developing countries and treatment of Community Acquired Bacterial Pneumonia (CABP) are expected to impart the market growth. Growing resistance of infection to the drug therapies, high price of drugs, competition between generic manufacturers and perilous reimbursement policies will impede market growth.

Based on Product, most of the Antibacterial agents are in pipeline for the modifications of existing antibiotic classes. More innovative products are required against pathogens with no cross- or co-resistance to existing classes. Many of the products in the clinical pipeline are already funded by research grants from public and philanthropic institutions.For instance, Delafloxacin was approved by the US Food and Drug Administration on 21 June 2017.
 
North America commanded the anti-infective agents market and is followed by Europe. Asia Pacific is the fastest growing market due to improvements in healthcare infrastructure, demand for drugs and ongoing government initiatives for various control programs.

Some of the key players in Global Anti-Infective Agents market are Pfizer Ltd, Ranbaxy Laboratories Ltd, Sun Pharmaceutical Industries Ltd., AstraZeneca Plc, Boehringer Ingelheim, Bristol-Myers Squibb Co, Abbott Laboratories, Bayer Healthcare AG, Cipla Ltd, GlaxoSmithKline Pharmaceuticals Ltd, Merck & Co., Inc, Novartis AG, Glenmark Pharmaceuticals Ltd, Lupin Ltd, Panacea Biotech Ltd and Claris Life Sciences Ltd.

Products Covered:
• Antifungal agents
• Antiviral agents
• Antituberculosis agents
• Antitreponemal agents
• Vaccines
• Antibacterial agents

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary        
          
2 Preface  
       
 2.1 Abstract        
 2.2 Stake Holders       
 2.3 Research Scope       
 2.4 Research Methodology       
  2.4.1 Data Mining      
  2.4.2 Data Analysis      
  2.4.3 Data Validation      
  2.4.4 Research Approach      
 2.5 Research Sources       
  2.5.1 Primary Research Sources     
  2.5.2 Secondary Research Sources     
  2.5.3 Assumptions                          
          
3 Market Trend Analysis        
 3.1 Introduction        
 3.2 Drivers        
 3.3 Restraints        
 3.4 Opportunities       
 3.5 Threats        
 3.6 Product Analysis       
 3.7 Emerging Markets       
 3.8 Futuristic Market Scenario      
          
4 Porters Five Force Analysis       
 4.1 Bargaining power of suppliers      
 4.2 Bargaining power of buyers      
 4.3 Threat of substitutes       
 4.4 Threat of new entrants       
 4.5 Competitive rivalry       
          
5 Anti-Infective Agents Market, By Product      
 5.1 Introduction        
 5.2 Antifungal agents       
  5.2.1 Azoles        
   5.2.1.1 Posaconazole     
   5.2.1.2 Clotrimazole     
   5.2.1.3 Fluconazole     
   5.2.1.4 Itraconazole     
   5.2.1.5 Ketoconazole     
   5.2.1.6 Voriconazole     
  5.2.2 Polyenes       
  5.2.3 Allylamines      
  5.2.4 Macrolides derivatives     
  5.2.5 Cresemba      
  5.2.6 Echinocandins       
 5.3 Antiviral agents        
  5.3.1 Non-structural protein 5A (NS5A) inhibitors   
  5.3.2 Non-nucleoside reverse transcriptase inhibitors (NNRTIs)  
  5.3.3 Protease Inhibitors      
  5.3.4 Transcriptase Inhibitors     
  5.3.5 Neuraminidase inhibitors     
  5.3.6 Integrase strand transfer inhibitor    
  5.3.7 Chemokine receptor antagonist    
  5.3.8 DNA Polymerase Inhibitors     
  5.3.9 Nucleoside Analogs      
   5.3.9.1 Purine Nucleosides     
   5.3.9.2 Pyrimidine Nucleosides    
 5.4 Antituberculosis agents      
  5.4.1 Nicotinic acid derivatives     
  5.4.2 Rifamycin derivatives     
  5.4.3 Streptomyces derivatives     
  5.4.4 Aminosalicylates      
  5.4.5 Diarylquinolines      
  5.4.6 Hydrazide derivatives     
 5.5 Antitreponemal agents       
 5.6 Vaccines        
  5.6.1 DNA & Recombinant vector Vaccines    
  5.6.2 Toxoid vaccines      
  5.6.3 Live/attenuated Vaccines     
  5.6.4 Inactivated Vaccines     
 5.7 Antibacterial agents        
  5.7.1 Clindamycin      
   5.7.1.1 B-Lactam Antibiotics    
   5.7.1.2 Oxazolidinones     
   5.7.1.3 Aminoglycosides     
   5.7.1.4 Quinolones     
  5.7.2 Sulfonamides      
  5.7.3 Tetracyclines      
  5.7.4 Vancomycin      
  5.7.5 Cephalosporins      
  5.7.6 Carbapenems      
  5.7.7 Fluoroquinolones      
  5.7.8 Penicillins       
   5.7.8.1 Penicillinase resistant penicillins   
   5.7.8.2 Natural penicillins     
   5.7.8.3 Beta-lactamase inhibitors    
   5.7.8.4 Antipseudomonal penicillins    
   5.7.8.5 Aminopenicillins     
  5.7.9 Macrolides       
   5.7.9.1 Erythromycin     
   5.7.9.2 Sulfisoxazole     
   5.7.9.3 Azithromycin     
   5.7.9.4 Clarithromycin XL     
          
6 Anti-Infective Agents Market, By Geography      
 6.1 Introduction        
 6.2 North America       
  6.2.1 US       
  6.2.2 Canada       
  6.2.3 Mexico       
 6.3 Europe        
  6.3.1 Germany       
  6.3.2 UK       
  6.3.3 Italy       
  6.3.4 France       
  6.3.5 Spain       
  6.3.6 Rest of Europe      
 6.4 Asia Pacific        
  6.4.1 Japan       
  6.4.2 China       
  6.4.3 India       
  6.4.4 Australia       
  6.4.5 New Zealand      
  6.4.6 South Korea      
  6.4.7 Rest of Asia Pacific      
 6.5 South America       
  6.5.1 Argentina      
  6.5.2 Brazil       
  6.5.3 Chile       
  6.5.4 Rest of South America     
 6.6 Middle East & Africa       
  6.6.1 Saudi Arabia      
  6.6.2 UAE       
  6.6.3 Qatar       
  6.6.4 South Africa      
  6.6.5 Rest of Middle East & Africa     
          
7 Key Player Activities        
 7.1 Acquisitions & Mergers       
 7.2 Agreements, Partnerships, Collaborations and Joint Ventures   
 7.3 Product Launch & Expansions       
 7.4 Other Activities       
          
8 Leading Companies        
 8.1 Pfizer Ltd        
 8.2 Ranbaxy Laboratories Ltd      
 8.3 Sun Pharmaceutical Industries Ltd.     
 8.4 AstraZeneca Plc       
 8.5 Boehringer Ingelheim       
 8.6 Bristol-Myers Squibb Co      
 8.7 Abbott Laboratories       
 8.8 Bayer Healthcare AG       
 8.9 Cipla Ltd        
 8.10 GlaxoSmithKline Pharmaceuticals Ltd     
 8.11 Merck & Co., Inc       
 8.12 Novartis AG        
 8.13 Glenmark Pharmaceuticals Ltd      
 8.14 Lupin Ltd        
 8.15 Panacea Biotech Ltd       
 8.16 Claris Life Sciences Ltd    


List of Tables         
Table 1 Global Anti-Infective Agents Market Outlook, By Region (2014-2023) ($MN)   
Table 2 Global Anti-Infective Agents Market Outlook, By Product (2014-2023) ($MN)   
Table 3 Global Anti-Infective Agents Market Outlook, By Antifungal agents (2014-2023) ($MN)  
Table 4 Global Anti-Infective Agents Market Outlook, By Azoles (2014-2023) ($MN)   
Table 5 Global Anti-Infective Agents Market Outlook, By Polyenes (2014-2023) ($MN)  
Table 6 Global Anti-Infective Agents Market Outlook, By Allylamines (2014-2023) ($MN)  
Table 7 Global Anti-Infective Agents Market Outlook, By Macrolides derivatives (2014-2023) ($MN) 
Table 8 Global Anti-Infective Agents Market Outlook, By Cresemba (2014-2023) ($MN)  
Table 9 Global Anti-Infective Agents Market Outlook, By Echinocandins (2014-2023) ($MN)  
Table 10 Global Anti-Infective Agents Market Outlook, By Antiviral agents (2014-2023) ($MN)  
Table 11 Global Anti-Infective Agents Market Outlook, By Non-structural protein 5A (NS5A) inhibitors (2014-2023) ($MN)
Table 12 Global Anti-Infective Agents Market Outlook, By Non-nucleoside reverse transcriptase inhibitors (NNRTIs) (2014-2023) ($MN)
Table 13 Global Anti-Infective Agents Market Outlook, By Protease Inhibitors (2014-2023) ($MN) 
Table 14 Global Anti-Infective Agents Market Outlook, By Transcriptase Inhibitors (2014-2023) ($MN) 
Table 15 Global Anti-Infective Agents Market Outlook, By Neuraminidase inhibitors (2014-2023) ($MN) 
Table 16 Global Anti-Infective Agents Market Outlook, By Integrase strand transfer inhibitor (2014-2023) ($MN)
Table 17 Global Anti-Infective Agents Market Outlook, By Chemokine receptor antagonist (2014-2023) ($MN)
Table 18 Global Anti-Infective Agents Market Outlook, By DNA Polymerase Inhibitors (2014-2023) ($MN) 
Table 19 Global Anti-Infective Agents Market Outlook, By Nucleoside Analogs (2014-2023) ($MN) 
Table 20 Global Anti-Infective Agents Market Outlook, By Antituberculosis agents (2014-2023) ($MN) 
Table 21 Global Anti-Infective Agents Market Outlook, By Nicotinic acid derivatives (2014-2023) ($MN) 
Table 22 Global Anti-Infective Agents Market Outlook, By Rifamycin derivatives (2014-2023) ($MN) 
Table 23 Global Anti-Infective Agents Market Outlook, By Streptomyces derivatives (2014-2023) ($MN) 
Table 24 Global Anti-Infective Agents Market Outlook, By Aminosalicylates (2014-2023) ($MN)  
Table 25 Global Anti-Infective Agents Market Outlook, By Diarylquinolines (2014-2023) ($MN)  
Table 26 Global Anti-Infective Agents Market Outlook, By Hydrazide derivatives (2014-2023) ($MN) 
Table 27 Global Anti-Infective Agents Market Outlook, By Antitreponemal agents (2014-2023) ($MN) 
Table 28 Global Anti-Infective Agents Market Outlook, By Vaccines (2014-2023) ($MN)  
Table 29 Global Anti-Infective Agents Market Outlook, By DNA & Recombinant vector Vaccines (2014-2023) ($MN)
Table 30 Global Anti-Infective Agents Market Outlook, By Toxoid vaccines (2014-2023) ($MN)  
Table 31 Global Anti-Infective Agents Market Outlook, By Live/attenuated Vaccines (2014-2023) ($MN) 
Table 32 Global Anti-Infective Agents Market Outlook, By Inactivated Vaccines (2014-2023) ($MN) 
Table 33 Global Anti-Infective Agents Market Outlook, By Antibacterial agents (2014-2023) ($MN) 
Table 34 Global Anti-Infective Agents Market Outlook, By Clindamycin (2014-2023) ($MN)  
Table 35 Global Anti-Infective Agents Market Outlook, By Sulfonamides (2014-2023) ($MN)  
Table 36 Global Anti-Infective Agents Market Outlook, By Tetracyclines (2014-2023) ($MN)  
Table 37 Global Anti-Infective Agents Market Outlook, By Vancomycin (2014-2023) ($MN)  
Table 38 Global Anti-Infective Agents Market Outlook, By Cephalosporins (2014-2023) ($MN)  
Table 39 Global Anti-Infective Agents Market Outlook, By Carbapenems (2014-2023) ($MN)  
Table 40 Global Anti-Infective Agents Market Outlook, By Fluoroquinolones (2014-2023) ($MN)  
Table 41 Global Anti-Infective Agents Market Outlook, By Penicillins (2014-2023) ($MN)  
Table 42 Global Anti-Infective Agents Market Outlook, By Penicillinase resistant penicillins (2014-2023) ($MN)
Table 43 Global Anti-Infective Agents Market Outlook, By Natural penicillins (2014-2023) ($MN)  
Table 44 Global Anti-Infective Agents Market Outlook, By Beta-lactamase inhibitors (2014-2023) ($MN) 
Table 45 Global Anti-Infective Agents Market Outlook, By Antipseudomonal penicillins (2014-2023) ($MN)
Table 46 Global Anti-Infective Agents Market Outlook, By Aminopenicillins (2014-2023) ($MN)  
Table 47 Global Anti-Infective Agents Market Outlook, By Macrolides (2014-2023) ($MN)  
Table 48 Global Anti-Infective Agents Market Outlook, By Erythromycin (2014-2023) ($MN)  
Table 49 Global Anti-Infective Agents Market Outlook, By Sulfisoxazole (2014-2023) ($MN)  
Table 50 Global Anti-Infective Agents Market Outlook, By Azithromycin (2014-2023) ($MN)  
Table 51 Global Anti-Infective Agents Market Outlook, By Clarithromycin XL (2014-2023) ($MN)  

Note: North America, Europe, Asia Pacific, South America, Middle East and Africa are represented in above manner.

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials